Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of MenAC-Hib Conjugate Vaccine Booster in 18-24 Month Old Children
CTR20190698Phase 3Completed
- Sponsor
- Zhifei Biological
- Start
- May 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal groups a and c and haemophilus b conjugate vaccine in meningococcal disease, Haemophilus influenzae type b disease (Hib), sponsored by Zhifei Biological. Started May 2019; status: completed.
02
Drugs
meningococcal groups a and c and haemophilus b conjugate vaccine
03
Conditions
meningococcal diseaseHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on CTR20190698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190698.